Abstract
P012 Survival outcomes and toxicities of adjuvant docetaxel-cyclophosphamide for four cycles in node negative triple negative and HER2 positive Chinese breast cancer patients: A 10 year follow up study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
